Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL)

CompletedOBSERVATIONAL
Enrollment

219

Participants

Timeline

Start Date

May 9, 2017

Primary Completion Date

October 11, 2019

Study Completion Date

September 4, 2021

Conditions
Diffuse Large B Cell Lymphoma
Interventions
PROCEDURE

Biological samples collection

In addition to collection and characterization of tumor biopsy samples done for diagnosis (standard care), collection of blood samples at study entry for further biological analyses.

Trial Locations (15)

14000

CHU Caen, Caen

21034

CHU Le Bocage, Dijon

31059

IUCT Oncopôle - CHU de Toulouse, Toulouse

33604

Centre Francois Magendie, Pessac

34295

CHU Montpellier, Montpellier

44093

CHU de Nantes, Nantes

54511

CHU Nancy Brabois, Vandœuvre-lès-Nancy

59037

CHU Claude Hurriez, Lille

69495

CHU Lyon Sud, Pierre-Bénite

74370

Ch Annecy Genevois, Pringy

76038

Centre Henri Becquerel, Rouen

85925

CH Départemental, La Roche-sur-Yon

86021

CHU de Poitiers - Hôpital de la Miletrie, Poitiers

94010

Hopital Henri Mondor, Créteil

94805

Institut Gustave Roussy, Villejuif

All Listed Sponsors
lead

The Lymphoma Academic Research Organisation

OTHER

NCT03104478 - Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL) | Biotech Hunter | Biotech Hunter